{"title":"急性白血病和骨髓增生异常综合征染色体不稳定形态标记的预后意义","authors":"Anju Khairwa, M. Kotru, Pooja Dewan, Shiva Narang","doi":"10.4314/gmj.v58i2.6","DOIUrl":null,"url":null,"abstract":"Objective: This study aimed to assess the prognostic significance of various morphological markers of chromosomal instability (CI).Design: This is a cross-sectional analytical study.Setting: Single centre study from the Department of Pathology of a tertiary care centre in India.Participants: The study included samples of bone marrow aspirates (BMA) and biopsies of patients with acute leukaemia (AL) and myelodysplastic syndrome (MDS) performed between June 2019 and June 2021. Inadequate samples were excluded. We included 178 samples from 80 cases.Interventions: BMA and biopsies slides examined for CI markers like chromatin bridges, multipolar mitosis, nuclear budding, micronuclei, laggards, chromatin string (CS) and nuclear heterogeneity (NH). CI markers were correlated with the type, severity and prognosis of acute leukaemia and MDS.Main outcome measures: Evaluation of CI markers as prognostic markers in AL and MDS.Results: We included B-cell ALL (35), AML (11), MDS (04), relapse of AL (12), and remission of AL (116). All CI markers were significantly increased in AL and MDS compared to the remission group. All CI markers were significantly higher in non-responders to therapy than in responders. In regression analysis, the median (IQR) values of CS and NH were significantly higher among non-survivors than survivors.Conclusion: CI markers of morphology are significantly associated with poor prognosis, including Non-survival of the disease. These markers are easy to identify and cost-effective. We recommend incorporating morphological markers of CI in routine reporting of haematological malignancies to assist in prognostication before reports from sophisticated techniques are available.","PeriodicalId":94319,"journal":{"name":"Ghana medical journal","volume":"19 9","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prognostic significance of morphology markers of chromosomal instability in acute leukaemia and myelodysplastic syndrome\",\"authors\":\"Anju Khairwa, M. Kotru, Pooja Dewan, Shiva Narang\",\"doi\":\"10.4314/gmj.v58i2.6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: This study aimed to assess the prognostic significance of various morphological markers of chromosomal instability (CI).Design: This is a cross-sectional analytical study.Setting: Single centre study from the Department of Pathology of a tertiary care centre in India.Participants: The study included samples of bone marrow aspirates (BMA) and biopsies of patients with acute leukaemia (AL) and myelodysplastic syndrome (MDS) performed between June 2019 and June 2021. Inadequate samples were excluded. We included 178 samples from 80 cases.Interventions: BMA and biopsies slides examined for CI markers like chromatin bridges, multipolar mitosis, nuclear budding, micronuclei, laggards, chromatin string (CS) and nuclear heterogeneity (NH). CI markers were correlated with the type, severity and prognosis of acute leukaemia and MDS.Main outcome measures: Evaluation of CI markers as prognostic markers in AL and MDS.Results: We included B-cell ALL (35), AML (11), MDS (04), relapse of AL (12), and remission of AL (116). All CI markers were significantly increased in AL and MDS compared to the remission group. All CI markers were significantly higher in non-responders to therapy than in responders. In regression analysis, the median (IQR) values of CS and NH were significantly higher among non-survivors than survivors.Conclusion: CI markers of morphology are significantly associated with poor prognosis, including Non-survival of the disease. These markers are easy to identify and cost-effective. We recommend incorporating morphological markers of CI in routine reporting of haematological malignancies to assist in prognostication before reports from sophisticated techniques are available.\",\"PeriodicalId\":94319,\"journal\":{\"name\":\"Ghana medical journal\",\"volume\":\"19 9\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ghana medical journal\",\"FirstCategoryId\":\"0\",\"ListUrlMain\":\"https://doi.org/10.4314/gmj.v58i2.6\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ghana medical journal","FirstCategoryId":"0","ListUrlMain":"https://doi.org/10.4314/gmj.v58i2.6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
研究目的本研究旨在评估染色体不稳定性(CI)各种形态学标志物的预后意义:这是一项横断面分析研究:印度一家三级医疗中心病理科的单中心研究:研究包括2019年6月至2021年6月期间进行的急性白血病(AL)和骨髓增生异常综合征(MDS)患者的骨髓穿刺(BMA)和活检样本。不足的样本被排除在外。我们纳入了来自 80 个病例的 178 份样本:BMA和活检切片检查染色质桥、多极有丝分裂、核出芽、微核、落后者、染色质串(CS)和核异质性(NH)等CI标记物。CI标记与急性白血病和MDS的类型、严重程度和预后相关:主要结果指标:评估作为AL和MDS预后标志物的CI标志物:我们纳入了B细胞ALL(35例)、AML(11例)、MDS(04例)、AL复发(12例)和AL缓解(116例)。与缓解组相比,AL和MDS的所有CI标志物均明显升高。治疗无反应者的所有 CI 指标均明显高于有反应者。在回归分析中,非存活者的 CS 和 NH 中位值(IQR)明显高于存活者:结论:CI 形态学标志物与不良预后(包括非存活)密切相关。这些标志物易于识别且具有成本效益。我们建议在血液恶性肿瘤的常规报告中纳入 CI 形态学标志物,以便在获得复杂技术报告之前协助预后判断。
Prognostic significance of morphology markers of chromosomal instability in acute leukaemia and myelodysplastic syndrome
Objective: This study aimed to assess the prognostic significance of various morphological markers of chromosomal instability (CI).Design: This is a cross-sectional analytical study.Setting: Single centre study from the Department of Pathology of a tertiary care centre in India.Participants: The study included samples of bone marrow aspirates (BMA) and biopsies of patients with acute leukaemia (AL) and myelodysplastic syndrome (MDS) performed between June 2019 and June 2021. Inadequate samples were excluded. We included 178 samples from 80 cases.Interventions: BMA and biopsies slides examined for CI markers like chromatin bridges, multipolar mitosis, nuclear budding, micronuclei, laggards, chromatin string (CS) and nuclear heterogeneity (NH). CI markers were correlated with the type, severity and prognosis of acute leukaemia and MDS.Main outcome measures: Evaluation of CI markers as prognostic markers in AL and MDS.Results: We included B-cell ALL (35), AML (11), MDS (04), relapse of AL (12), and remission of AL (116). All CI markers were significantly increased in AL and MDS compared to the remission group. All CI markers were significantly higher in non-responders to therapy than in responders. In regression analysis, the median (IQR) values of CS and NH were significantly higher among non-survivors than survivors.Conclusion: CI markers of morphology are significantly associated with poor prognosis, including Non-survival of the disease. These markers are easy to identify and cost-effective. We recommend incorporating morphological markers of CI in routine reporting of haematological malignancies to assist in prognostication before reports from sophisticated techniques are available.